Advances in clinical research and new form of docetaxel
10.3760/cma.j.issn.1008-6706.2016.19.039
- VernacularTitle:多西他赛的临床应用及其新剂型的研究进展
- Author:
Guangxuan LIU
;
Yue SUI
;
Qian ZHAO
;
Jiayi LIU
- Publication Type:Journal Article
- Keywords:
Docetaxel;
Anticancer;
Clinical progress;
New dosage forms
- From:
Chinese Journal of Primary Medicine and Pharmacy
2016;23(19):3029-3034
- CountryChina
- Language:Chinese
-
Abstract:
Docetaxel (DXT)is a member of the taxane drug class,which is used to treat breast cancer,lung cancer,gastric cancer,prostate cancer and so on.Docetaxel can be used as a single agent or in combination with other chemotherapeutic drugs.Many side effects of docetaxel have been reported in recent years.New dosage forms are developed to reduce toxicity and increase efficacy.An overview of these novel formulations of docetaxel and clinical progress will be discussed by consulting 43 literatures.
